S&P 500   3,855.36 (+0.36%)
DOW   30,960.00 (-0.12%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
S&P 500   3,855.36 (+0.36%)
DOW   30,960.00 (-0.12%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
S&P 500   3,855.36 (+0.36%)
DOW   30,960.00 (-0.12%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
S&P 500   3,855.36 (+0.36%)
DOW   30,960.00 (-0.12%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
Log in
CVE:VRS

Verisante Technology Inc. (VRS.V) Stock Forecast, Price & News

C$0.02
+0.02 (+∞)
(As of 04/23/2018)
Add
Compare
Today's Range
C$0.02
Now: C$0.02▼
C$0.02
50-Day Range
C$0.02
MA: C$0.02▼
C$0.02
52-Week Range
C$0.01
Now: C$0.02▼
C$0.06
Volume197,000 shs
Average Volume256,747 shs
Market CapitalizationC$1.97 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Verisante Technology Inc., a medical device company, engages in commercializing skin cancer detection systems. The company's products comprise Verisante Aura, which helps in the detection of various forms of skin cancer, including basal cell and squamous cell carcinoma, and melanoma; and Verisante Core for the detection of lung, cervical, gastrointestinal, and colo-rectal cancers. It also owns all the rights to the ClearVu and ClearVu Elite endoscopy systems for the detection of lung cancer. Verisante Technology has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was founded in 2006 and is based in Richmond, Canada.

MarketRank™

Overall MarketRank™

0.52 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange CVE
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolCVE:VRS
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.verisante.com
Phone+1-604-6050507
EmployeesN/A
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares98,616,000
Market CapC$1.97 million
Next Earnings DateN/A
OptionableOptionable
C$0.02
+0.02 (+∞)
(As of 04/23/2018)
30 days | 90 days | 365 days | Advanced Chart

Receive VRS News and Ratings via Email

Sign-up to receive the latest news and ratings for VRS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Verisante Technology Inc. (VRS.V) (CVE:VRS) Frequently Asked Questions

What stocks does MarketBeat like better than Verisante Technology Inc. (VRS.V)?

Wall Street analysts have given Verisante Technology Inc. (VRS.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Verisante Technology Inc. (VRS.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Verisante Technology Inc. (VRS.V)'s key competitors?

Some companies that are related to Verisante Technology Inc. (VRS.V) include Smith & Nephew plc (SN.L) (SN), Corindus Vascular Robotics (CVRS), Consort Medical plc (CSRT.L) (CSRT), EKF Diagnostics Holdings plc (EKF.L) (EKF), Immunodiagnostic Systems Holdings PLC (IDH.L) (IDH), Theralase Technologies Inc. (TLT.V) (TLT), Intelligent Ultrasound Group plc (MED.L) (MED), LiDCO Group Plc (LID.L) (LID), Deltex Medical Group plc (DEMG.L) (DEMG), Zecotek Photonics Inc. (ZMS.V) (ZMS), Caliber Imaging & Diagnostics (LCDX) and MCP Income Opportunities Trust (MOT.AX) (MOT).
View all of VRS's competitors.

Who are Verisante Technology Inc. (VRS.V)'s key executives?

Verisante Technology Inc. (VRS.V)'s management team includes the following people:
  • Mr. Thomas A. Braun BA, J.D., LLM, Chief Exec. Officer, Pres and Director (Age 50)
  • Ms. Anna Trinh B.Comm LLB, Chief Financial Officer, Corp. Counsel and Sec. (Age 44)
  • Mr. Rizah Bahic, Exec. Officer

What is Verisante Technology Inc. (VRS.V)'s stock symbol?

Verisante Technology Inc. (VRS.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VRS."

How do I buy shares of Verisante Technology Inc. (VRS.V)?

Shares of VRS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Verisante Technology Inc. (VRS.V)'s stock price today?

One share of VRS stock can currently be purchased for approximately C$0.02.

How big of a company is Verisante Technology Inc. (VRS.V)?

Verisante Technology Inc. (VRS.V) has a market capitalization of C$1.97 million.

What is Verisante Technology Inc. (VRS.V)'s official website?

The official website for Verisante Technology Inc. (VRS.V) is www.verisante.com.

How can I contact Verisante Technology Inc. (VRS.V)?

Verisante Technology Inc. (VRS.V)'s mailing address is 2309 41st Ave W Suite 306, VANCOUVER, BC V6M 2A3, Canada. The company can be reached via phone at +1-604-6050507.

This page was last updated on 1/25/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.